Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
Metrics to compare | 000100 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000100PeersSector | |
|---|---|---|---|---|
P/E Ratio | 110.3x | 14.1x | −0.5x | |
PEG Ratio | 0.22 | 0.01 | 0.00 | |
Price/Book | 3.4x | 1.1x | 2.6x | |
Price / LTM Sales | 3.5x | 0.8x | 3.1x | |
Upside (Analyst Target) | 50.8% | 21.2% | 53.1% | |
Fair Value Upside | Unlock | 11.6% | 7.1% | Unlock |